相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer
K-F Hsu et al.
BRITISH JOURNAL OF CANCER (2015)
A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis
Robert W. Schnepp et al.
CANCER CELL (2015)
Acquired Resistance to EGFR Inhibitors Is Associated with a Manifestation of Stem Cell-like Properties in Cancer Cells
Kazuhiko Shien et al.
CANCER RESEARCH (2013)
Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis
Wen Cai Zhang et al.
CELL (2012)
Knockdown of the Epidermal Growth Factor Receptor Gene to Investigate Its Therapeutic Potential for the Treatment of Non-Small-Cell Lung Cancers
Kazuhiko Shien et al.
CLINICAL LUNG CANCER (2012)
Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy
Kazuhiko Shien et al.
LUNG CANCER (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
V. Davalos et al.
ONCOGENE (2012)
Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Elena Piskounova et al.
CELL (2011)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells
Yoshihiro Takeyama et al.
CANCER LETTERS (2010)
Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells
Xiaojun Yang et al.
CANCER RESEARCH (2010)
MicroRNA Expression Differentiates Histology and Predicts Survival of Lung Cancer
Maria Teresa Landi et al.
CLINICAL CANCER RESEARCH (2010)
Accurate Classification of Non-Small Cell Lung Carcinoma Using a Novel MicroRNA-Based Approach
Justin A. Bishop et al.
CLINICAL CANCER RESEARCH (2010)
The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?
Simone Brabletz et al.
EMBO REPORTS (2010)
Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
Paolo Ceppi et al.
MOLECULAR CANCER RESEARCH (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
Dejuan Kong et al.
PLOS ONE (2010)
MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer
Mitch Raponi et al.
CANCER RESEARCH (2009)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
Let-7 and miR-200 microRNAs Guardians against pluripotency and cancer progression
Marcus E. Peter
CELL CYCLE (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation
Tsung-Cheng Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinicopathological features and epidermal growth factor receptor mutations associated with epithelial-mesenchymal transition in non-small cell lung cancer
Qin-Fang Deng et al.
RESPIROLOGY (2009)
MicroRNA signature predicts survival and relapse in lung cancer
Sung-Liang Yu et al.
CANCER CELL (2008)
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
Seiji Yano et al.
CANCER RESEARCH (2008)
MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
James Bean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression
Hui-Wen Lo et al.
CANCER RESEARCH (2007)
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Jeffrey A. Engelman et al.
SCIENCE (2007)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
A Angelucci et al.
ENDOCRINE-RELATED CANCER (2006)
Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines
SE Witta et al.
CANCER RESEARCH (2006)
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
RL Yauch et al.
CLINICAL CANCER RESEARCH (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins
RD Ramirez et al.
CANCER RESEARCH (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival
J Takamizawa et al.
CANCER RESEARCH (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
